Opposing roles of NF-κB in anti-cancer treatment outcome unveiled by cross-species investigations
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
In malignancies, enhanced nuclear factor-κB (NF-κB) activity is largely viewed as an oncogenic property that also confers resistance to chemotherapy. Recently, NF-κB has been postulated to participate in a senescence-associated and possibly senescence-reinforcing cytokine response, thereby suggesting a tumor-restraining role for NF-κB. Using a mouse lymphoma model and analyzing transcriptome and clinical data from lymphoma patients, we show here that therapy-induced senescence presents with and depends on active NF-κB signaling, whereas NF-κB simultaneously promotes resistance to apoptosis. Further characterization and genetic engineering of primary mouse lymphomas according to distinct NF-κB-related oncogenic networks reminiscent of diffuse large B-cell lymphoma (DLBCL) subtypes guided us to identify Bcl2-overexpressing germinal center B-cell-like (GCB) DLBCL as a clinically relevant subgroup with significantly superior outcome when NF-κB is hyperactive. Our data illustrate the power of cross-species investigations to functionally test genetic mechanisms in transgenic mouse tumors that recapitulate distinct features of the corresponding human entity, and to ultimately use the mouse model-derived genetic information to redefine novel, clinically relevant patient subcohorts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 2×
“While oncogene-induced senescence (OIS), most thoroughly studied in response to Ras/Raf-type oncogenes, imposes an anti-tumor barrier in early, (pre)malignant lesions (Serrano et al. 1997; Braig et al. 2005), therapy-induced senescence (TIS) has been shown to improve the long-term outcome of cancer therapy (Schmitt et…”
BackgroundSenescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473 · cited 3×
“2008), an array of predominantly proinflammatory cytokines whose autocrine or paracrine action reportedly reinforces the senescent arrest at least in some settings and whose cross-talk to the innate host immune systemmight explain the immune-mediated clearance of senescent tumor cells (Xue et al. 2007; Acosta et al. 2…”
BackgroundOncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086 · cited 3×
“Many of the SASP factors are bona fide NF-kB targets with NF-kB-binding sites in their promoters (Feuerhake et al. 2005; Acosta et al. 2008; Kuilman et al. 2008), rendering them responsive to NF-kB activation, as shown for poly(ADP-ribose)-polymerase-1 (PARP-1)mediated genotoxic therapies or…”
BackgroundThe essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038
Chemokine signaling via the CXCR2 receptor reinforces senescence
Acosta, J. C., O'Loghlen, A., Banito, A., Guijarro, M. V., Augert, A., Raguz, S., Fumagalli, M., Da Costa, M., Brown, C., Popov, N., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.038 · Cited by 1,801 · cited 6×
“putative prosenescent NF-kB-governed functions in a homotypic tumor cell population—irrespective of their intracellular, autocrine, or paracrine modes of action (Acosta et al. 2008; Kuilman et al. 2008)—at least in a subset of genetically susceptible primary tumors.”
BackgroundInfluentialOncogene-induced senescence as an initial barrier in lymphoma development
Braig, M., Lee, S., Loddenkemper, C., Rudolph, C., Peters, A. H. F. M., Schlegelberger, B., Stein, H., Dörken, B., Jenuwein, T., & Schmitt, C. A. (2005) · Nature · doi:10.1038/nature03841 · Cited by 1,220
Self-citationA Senescence Program Controlled by p53 and p16INK4a Contributes to the Outcome of Cancer Therapy
Schmitt, C. A., Fridman, J. S., Yang, M., Lee, S., Baranov, E., Hoffman, R. M., & Lowe, S. W. (2002) · Cell · doi:10.1016/s0092-8674(02)00734-1 · Cited by 1,050
Self-citationChien, Y., Scuoppo, C., Wang, X., Fang, X., Balgley, B., Bolden, J. E., Premsrirut, P., Luo, W., Chicas, A., Lee, C. S., et al. (2011) · Genes & Development · doi:10.1101/gad.17276711 · Cited by 1,046
Good cop, bad cop: the different faces of NF-κB
Perkins, N. D., & Gilmore, T. D. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401838 · Cited by 489 · cited 1×
“…model-based studies found NF-kB transcription factors or upstream activators rather to act as tumor suppressors (Luedde et al. 2007; Keller et al. 2010), thereby underscoring the complexity and potential context dependency of NF-kB network-mediated effector functions (Perkins and Gilmore 2006).”
Background
Research works printed but not linked: 34
- 10.1038/318533a0 · DOI · Paper page
- 10.1182/blood-2010-09-297879 · DOI · Paper page
- 10.1038/ni.2060 · DOI · Paper page
- 10.1172/JCI115354 · DOI · Paper page
- 10.1074/jbc.M409825200 · DOI · Paper page
- 10.1016/j.ccr.2010.11.024 · DOI · Paper page
- 10.1038/nature07968 · DOI · Paper page
- 10.1084/jem.194.12.1861 · DOI · Paper page
- 10.1073/pnas.92.20.9363 · DOI · Paper page
- 10.1182/blood-2009-01-199679 · DOI · Paper page
- 10.1182/blood-2004-12-4901 · DOI · Paper page
- 10.1074/jbc.272.39.24113 · DOI · Paper page
- 10.1016/j.cell.2008.01.020 · DOI · Paper page
- 10.1056/NEJM199309303291402 · DOI · Paper page
- 10.1200/JCO.2005.03.4264 · DOI · Paper page
- 10.1186/1471-2407-10-348 · DOI
- 1996, Different mechanisms control signal-induced degradation and basal turnover of the NF-κB inhibitor IκBα in vivo, EMBO J, 15, 6716, 10.1002/j.1460-2075.1996.tb01061.x · DOI · Paper page
- 10.1126/science.1153629 · DOI · Paper page
- 10.1056/NEJMoa0802885 · DOI · Paper page
- 2010, Targeting transcription factor NF-κB to overcome chemoresistance and radioresistance in cancer therapy, Biochim Biophys Acta, 1805, 167
- 10.1016/j.ccr.2006.12.016 · DOI · Paper page
- 10.1038/nature04687 · DOI · Paper page
- 10.1200/JCO.2010.33.3252 · DOI · Paper page
- 10.1182/blood-2007-02-075614 · DOI · Paper page
- 10.1038/onc.2010.611 · DOI · Paper page
- 10.1200/JCO.2010.31.1142 · DOI · Paper page
- 10.1038/35009130 · DOI · Paper page
- 10.1038/79542 · DOI · Paper page
- 10.1093/jnci/djn174 · DOI
- 10.1016/0092-8674(86)90346-6 · DOI · Paper page
- 10.1111/j.0105-2896.2006.00373.x · DOI · Paper page
- 10.1126/science.281.5383.1680 · DOI · Paper page
- 10.1038/7410 · DOI · Paper page
- 10.1172/JCI42358 · DOI · Paper page
Cited by
A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2784 · Cited by 2,278
Senescence-associated reprogramming promotes cancer stemness
Milanovic, M., Fan, D. N. Y., Belenki, D., Däbritz, J. H. M., Zhao, Z., Yu, Y., Dörr, J. R., Dimitrova, L., Lenze, D., Monteiro Barbosa, I. A., et al. (2018) · Nature · doi:10.1038/nature25167 · Cited by 1,131
Self-citationChien, Y., Scuoppo, C., Wang, X., Fang, X., Balgley, B., Bolden, J. E., Premsrirut, P., Luo, W., Chicas, A., Lee, C. S., et al. (2011) · Genes & Development · doi:10.1101/gad.17276711 · Cited by 1,046
cGAS is essential for cellular senescence
Yang, H., Wang, H., Ren, J., Chen, Q., & Chen, Z. J. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1705499114 · Cited by 1,009
Cellular senescence and its effector programs
Salama, R., Sadaie, M., Hoare, M., & Narita, M. (2014) · Genes & Development · doi:10.1101/gad.235184.113 · Cited by 855
Metadata
- Authors
- Jing, H., Kase, J., Dörr, J. R., Milanovic, M., Lenze, D., Grau, M., Beuster, G., Ji, S., Reimann, M., Lenz, P., Hummel, M., Dörken, B., Lenz, G., Scheidereit, C., Schmitt, C. A., & Lee, S.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2011-10-06
- Volume
- 25
- Issue
- 20
- Pages
- 2137-2146
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2163924431
- Cited by
- 99
- References
- 20
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Opposing roles of NF-κB in anti-cancer treatment outcome unveiled by cross-species investigations. https://app.cochat.ai/papers/10.1101/gad.17620611
- The paper
- Jing, H., Kase, J., Dörr, J. R., Milanovic, M., Lenze, D., Grau, M., Beuster, G., Ji, S., Reimann, M., Lenz, P., Hummel, M., Dörken, B., Lenz, G., Scheidereit, C., Schmitt, C. A., & Lee, S. (2011). Opposing roles of NF-κB in anti-cancer treatment outcome unveiled by cross-species investigations. Genes & Development. https://doi.org/10.1101/gad.17620611
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.